Our Team in the News


BioPlan Associates' Ronald Rader

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.


BioPlan Associates' Faiz Kermani PhD

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org


BioPlan Associates' Managing Director Eric Langer

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.


About

WHo We Are

Eric Langer
Eric Langer, Managing Partner

Eric Langer, President and Managing Partner, has over 20 years experience in biotechnology and life sciences international marketing, management, market assessment, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He is an experienced biotechnology strategist, marketing practitioner, publisher, and researcher. He has published, edited and authored numerous books, reports, and major studies on topics including: Advances in Biopharmaceutical Technology in China, Advances in Large-scale Biopharmaceutical Manufacturing, Biopharmaceuticals in the US Market, cell culture reports, media, sera, tissue engineering, stem cells, diagnostic products, blood products, genetics, DNA/PCR purification, blood components, and many others. He lectures extensively on marketing, pricing and channel management topics, and teaches at Johns Hopkins University and American University: Biotechnology Marketing, Marketing Management, Services Marketing, Advertising Strategy, and Bioscience Communication. In 1989 he co-founded BioPlan Associates, Inc. He has launched and managed marketing programs for product lines ranging from $500k to $500 million.

Faiz Kermani
Dr Faiz Kermani, Senior Associate, Clinical

Dr Faiz Kermani has many years experience in both academia and the pharmaceutical industry. He has worked in pharmaceutical R&D, pricing and reimbursement, marketing and medical communications. He holds a PhD in Immunopharmacology from St. Thomas’ Hospital, London and a First Class Honours degree in Pharmacology with Toxicology from King’s College, London. He has written extensively on international healthcare issues, and is on the editorial board of a number of publications. In March 2006, he was a delegate on the UK Government’s Trade and Investment Biotech Scoping Mission to China and was a speaker at the subsequent presentation.

Ronald Rader
Ronald A. Rader, Senior Director, Technical Research

Mr. Ronald A. Rader is uniquely qualified, with a B.S. (Microbiology), M.L.S. (Library Science), and 25+ years experience as a biotechnology, pharmaceutical and chemical information specialist and publisher. From 1988, he was Editor/Publisher of the Antiviral Agents Bulletin, the only periodical specializing in antiviral/HIV drug and vaccine development. In 1994, he published the Federal Bio-Technology Transfer Directory, a 678-page book abstracting and indexing all federal laboratory, e.g., NIH, inventions and technology transfers in biotech/biomedical areas, further marketed as an online database until 2000. Mr. Rader published Biopharmaceutical Products in the U.S. Market first in April 2001. Mr. Rader has been Manager of Information Services, Porton International plc, Prior to that he served as a biomedical/chemical information specialist/manager/analyst with companies including Gillette Medical Evaluation Labs., Gillette Co.; MITRE Corp.; Biospherics; Computer Sciences Corp. (CSC); Technical Resources Inc.; and Bio-Conversion Labs.

Charlotte Bliss
Charlotte Bliss, Project Director

Ms. Bliss has over 20 years managing technology- and healthcare-based projects, and is project manager on studies including Advances in Large-scale Biopharmaceutical Manufacturing and Scale-up Production, 2nd Ed. She has worked in marketing research for Wyeth, Cigna, RMA, and other major organizations. Her background includes in-depth interviewing with executives, competitive intelligence, internet surveys, and secondary research. She has applied these skills in a variety of industries including pharmaceuticals, health care, financial services, and consumer products. Her market research management and industry analysis expertise covers topics in biopharmaceuticals from downstream purification, to disposables, and many other aspects. Charlotte holds an MS in instructional media and a BA in communication arts from the University of Wisconsin.

D. Elizabeth Stanley, Project Manager

Donnie Stanley has 10 years experience in marketing and healthcare research. She is editor and manager of industry newsletters including, BioCHINA, and BioINDIA. Her very extensive contacts in the biopharmaceutical industry ensure she is able to identify and bring in additional subject matter expertise when a project requires in-depth knowledge. In addition, she provides secondary marketing research services as well as primary qualitative research.

Gloria Jacobovitz
Dr. Gloria Jacobovitz, Senior Associate

Dr. Jacobovitz has over 20 years experience in bio-science international business development, marketing, market assessment and management with fortune 500 as well as startup companies. She has held senior management positions in Biotechnology and Biofuels, has co-founded technology based start-up companies, and is an accomplished researcher with many published peer reviewed papers and 6 filed patents. She holds a master in Biotechnology from Johns Hopkins University and a PhD in Applied Physics from UNICAMP (Sao Paulo, Brazil). In the field of Biofuels she has extensively consulted on solid biofuels made of energy crops. She has also participated in international forums on Brazilian and European biofuel markets, rules and regulations, market needs, & investors in sugar cane supply. She has developed corporate strategy, business & investment plan for bio-fuel start-ups that have resulted in $6 million equity investment, and has successfully developed international funds with the Inter American Development Bank for ~$80 million loans.

BioPlan Associates' Managing Director Lynn Johnson Langer
Lynn Johnson-Langer, Advisory Board Member

Dr Langer has her PhD from Antioch University in management; she graduated Johns Hopkins University, MBA, Business Management; University of Maryland, BS Microbiology. She works with biotechnology and life sciences organizations to improve clients’ management systems, including human resources and marketing management. Provide analysis of current management systems and develop customized programs to maximize effectiveness. As Director, Market Planning, BioCarb Inc., she was responsible for market planning and market research for international biopharmaceutical diagnostics and therapeutics company. Screened scientific discoveries for potential product development. She was responsible for business development, primary and secondary market research, and aspects of FDA Regulatory Affairs. In academics, as Special Assistant to the Dean, Senior Associate Program Chair, Biotechnology, Director, MS.MBA Biotechnology, Advanced Academic Programs, Johns Hopkins University, she chairs FDA-JHU conferences on Bayesian statistics, and academic program activities in biotechnology. She is responsible for faculty and curriculum development for Advanced Academic Programs: Regulatory Affairs and Enterprise Concentrations. She established the dual degree, MS.MBA Biotechnology program between Kreiger School and School of Professional Studies in Business and Education.

What We Deliver

Confidence. Our clients' decisions are based on customer needs, about what they want, need, and are willing to pay for. Our technology clients get the decision-making tools and actionable information they need to make decisions today:

We deliver to our customers the confidence they need to make more aggressive, rapid, tactical marketing decisions. Marketing managers feel more self-assured about their actions. Positive actions get more rapid, positive results. We provide highly targeted, actionable marketing research.

Our "Space"

Biopharmaceutical, biotech, diagnostics, and life sciences suppliers seeking customer needs analysis need to make smart decisions.